Clinical Trials Directory

Trials / Unknown

UnknownNCT03929991

Maternal Cesarian Section Infection (MACSI) in Sierra Leone

Maternal Cesarian Section Infection (MACSI) in Sierra Leone: an Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Doctors with Africa - CUAMM · Academic / Other
Sex
Female
Age
Healthy volunteers

Summary

Up to 1 in 5 women in Africa who deliver their baby by cesarean section get a wound infection. Surgical site infections (SSIs) are largely preventable, but they represent a considerable burden for health-care systems, particularly in low-income and middle-income countries. The prevention of these infections is complex and requires the integration of a range of preventive measures before, during, and after surgery. The aim of the proposed project is to determine the risk factors of Surgical Site Infection post-Cesarean Section in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and the predictors of a negative outcome in women with post-CS SSI.

Detailed description

Rationale: More than 1 in 10 people who have surgery in low and middle-income countries (LMICs) get surgical site infection. People's risk of SSI in LMICs is 3 to 5 times higher than in high-income countries. Up to 1 in 5 women in Africa who deliver their baby by cesarean section get a wound infection. Surgical site infections (SSIs) are largely preventable, but they represent a considerable burden for health-care systems, particularly in low-income and middle-income countries. The prevention of these infections is complex and requires the integration of a range of preventive measures before, during, and after surgery. Objective: The aim of the proposed project is to determine the risk factors of Surgical Site Infection post-Cesarean Section in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and the predictors of a negative outcome in women with post-CS SSI. Study design: This is a prospective case-control (1:3 ratio) study. Study population and Methods: All women admitted or already hospitalized with suspected or confirmed infection after C/S will be screened for inclusion in the study as a case. Case confirmation will be clinically established by an infectious disease expert. For each case, 3 patients undergoing the C/S on the same day and admitted to the same ward but not presenting SSI, will be selected as controls. Sample size: No formal sample size calculation is performed. Main study parameters/primary endpoints: SSI post C/S will be classified as: Superficial incisional surgical site infection, Deep incisional surgical site infection; Organ/space surgical site infection Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Because all proceedings in the method of this study are based on common clinical practice, there are no serious adverse events (SAEs) expected.

Conditions

Interventions

TypeNameDescription
OTHERObservationalTo record social and clinical characteristics

Timeline

Start date
2018-05-01
Primary completion
2019-10-01
Completion
2020-05-01
First posted
2019-04-29
Last updated
2019-04-30

Locations

1 site across 1 country: Sierra Leone

Source: ClinicalTrials.gov record NCT03929991. Inclusion in this directory is not an endorsement.